Steroid Hormone Receptor Isoform Diversity in Gynecologic Oncogenesis: Mechanisms, Biomarker Evidence, and Implications for Precision Oncology
World Journal of Oncology · 2026-12 · 17 (6) · 790-801
DOI: 10.14740/wjon2817 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Oncology, 2026-12. Verfasst von Apeksha Padakannaya und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Padakannaya, A., & Ratnacaram, C. K. (2026). Steroid Hormone Receptor Isoform Diversity in Gynecologic Oncogenesis: Mechanisms, Biomarker Evidence, and Implications for Precision Oncology. World Journal of Oncology, 17(6), 790-801. https://doi.org/10.14740/wjon2817
Vancouver
Padakannaya A, Ratnacaram CK. Steroid Hormone Receptor Isoform Diversity in Gynecologic Oncogenesis: Mechanisms, Biomarker Evidence, and Implications for Precision Oncology. World Journal of Oncology. 2026;17(6):790-801. doi:10.14740/wjon2817
BibTeX
@article{Padakannaya2026,
author = {Padakannaya, Apeksha and Ratnacaram, Chandrahas Koumar},
title = {Steroid Hormone Receptor Isoform Diversity in Gynecologic Oncogenesis: Mechanisms, Biomarker Evidence, and Implications for Precision Oncology},
journal = {World Journal of Oncology},
year = {2026},
volume = {17},
number = {6},
pages = {790--801},
doi = {10.14740/wjon2817}
}
EUVIMED